4//SEC Filing
INTERCEPT PHARMACEUTICALS INC 4
Accession 0001144204-13-056563
CIK 0001270073operating
Filed
Oct 22, 8:00 PM ET
Accepted
Oct 23, 9:31 PM ET
Size
6.0 KB
Accession
0001144204-13-056563
Insider Transaction Report
Form 4
TALLARIGO LORENZO
Director
Transactions
- Sale
Common Stock
2013-10-21$62.50/sh−124,912$7,807,000→ 5,938,890 total(indirect: See Footnote)
Holdings
- 3,111
Common Stock
Footnotes (2)
- [F1]These shares are held by Genextra S.p.A. Dr. Tallarigo is the chief executive officer of Genextra S.p.A. and, in such capacity, Dr. Tallarigo exercises voting control over the shares of common stock owned by Genextra S.p.A. and investment control over such shares as authorized by the board of directors of Genextra S.p.A. Dr. Tallarigo disclaims beneficial ownership with respect to any such shares, except to the extent of his pecuniary interest therein, if any.
- [F2]Represents shares of common stock sold under a registration statement on Form S-1 (File No. 333-191501) by Genextra S.p.A. to the underwriter on October 21, 2013 pursuant to the underwriter's partial exercise of its over-allotment option.
Documents
Issuer
INTERCEPT PHARMACEUTICALS INC
CIK 0001270073
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001270073
Filing Metadata
- Form type
- 4
- Filed
- Oct 22, 8:00 PM ET
- Accepted
- Oct 23, 9:31 PM ET
- Size
- 6.0 KB